Dana Dabelea, MD, PhD, Principal Investigator.
The DPPOS is the long-term follow-up of the landmark Diabetes Prevention Program (DPP) trial that showed that lifestyle changes or the drug metformin effectively delay diabetes in overweight or obese American adults. Follow-up now exceeds fifteen years and the participants are being studied for further diabetes, heart disease, as well as aging related changes, and cancer.
Researchers involved: Dana Dabelea, Leigh Perreault
Results from the 10 year follow-up showed that lifestyle and metformin continued to delay or prevent diabetes: